Faeth Therapeutics

FTH · NASDAQ

$20.79+$1.35 (+6.94%)TodayMarket closed ·
Prev close $19.44

Who owns FTH

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 56.5% of FTH’s shares.

  • VK Services, LLC10.2%
  • S2G Advisors, LLC10.0%
  • Montanova Capital, LLC7.8%
  • Avoro Capital Advisors LLC5.6%
  • Next 6 largest institutions22.8%
  • All other shareholders43.5%
Top institutional holders of FTH
HolderShares% of shares
VK Services, LLC2.63M10.21%
S2G Advisors, LLC2.58M9.99%
Montanova Capital, LLC2.02M7.84%
Avoro Capital Advisors LLC1.44M5.60%
Baker Bros. Advisors LP1.29M4.99%
Balyasny Asset Management LP1.04M4.04%
Cormorant Asset Management, LP1.03M3.99%
Polar Capital LLP986.89K3.83%
Parikh (Anand Kiran J.D.)817.70K3.17%
Fairmount Funds Management LLC722.02K2.80%

Largest mutual fund holders

Top mutual fund holders of FTH
HolderShares% of shares
Polar Capital Biotechnology Fund986.89K3.83%
Franklin Templeton Investment Funds -Biotechnology Discovery337.09K1.31%
Franklin Biotechnology Discovery Fund180.71K0.70%
Candriam Equities L Oncology103.19K0.40%
Fidelity NASDAQ Composite Index Fund15.91K0.06%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders bought $326.13K (6 trades) of FTH on the open market, with no sales.

Latest FTH insider transactions
InsiderTypeSharesValue
Vousden Karen HAward25.00K—
Parikh Anand KiranAward398.02K—
Craver JosiahAward30.82K—
STEPHENSON BRIAN CBuy600$14.53K
STEPHENSON BRIAN CBuy4.40K$102.96K
STEPHENSON BRIAN CBuy4.25K$106.29K
STEPHENSON BRIAN CBuy1.64K$39.12K
STEPHENSON BRIAN CBuy1.91K$43.83K
STEPHENSON BRIAN CBuy831$19.40K

Short interest

Settled Sep 30, 2026

Shares short
2.07M
Days to cover
3.63
% of shares outstanding
8.02%
Average daily volume
569.39K
Change since last report
+56.8%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.